PAR paradigm biopharmaceuticals limited..

LiveStream: Paradigm Biopharma (ASX:PAR) pursuing FDA review, page-3

  1. 1,556 Posts.
    lightbulb Created with Sketch. 522
    What even is this company anymore?

    The language has changed from we are a P3 company to we are doing the first part of 2 P3s to we are desperately hoping the FDA will let us get close to being a P3.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
33.0¢
Change
0.000(0.00%)
Mkt cap ! $131.1M
Open High Low Value Volume
32.5¢ 35.0¢ 31.8¢ $341.6K 1.052M

Buyers (Bids)

No. Vol. Price($)
1 30207 33.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 60000 2
View Market Depth
Last trade - 16.10pm 07/08/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.